由于心房而复杂的心力衰竭的口服抗凝药:全国一项例行数据研究
Martin Möckel1, Samipa Pudasaini1, Henning Thomas Baberg2
1Department of Emergency and Acute Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität zu Berlin, 13353/10117 Berlin, Germany.
International journal of cardiology
|October 12, 2023
概括
口服抗凝剂 (OAC) 降低了心力衰竭和心房动患者的死亡率和再入院率. 不同类型的OAC之间没有观察到显著的结果差异.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 和心房动 (AF) 是常见的并发症.
- 口服抗凝剂 (OAC) 对于管理AF患者中风风险至关重要.
- 在HF-AF患者中不同OAC的比较有效性需要进一步研究.
研究的目的:
- 评估OAC使用对HF和AF患者的死亡率和再入院率的影响.
- 为了比较新的口服抗凝剂 (NOACs) 与维生素K抗剂 (VKAs) 在这些结果中的有效性.
主要方法:
- 全国对匿名医疗保险索赔数据 (2017-2019年) 的分析.
- 包括诊断为HF和AF的患者,不包括之前住院治疗的患者.
- 分析死亡率和再入院率 (全因和中风/内出血) 住院后91-365天使用生存曲线和考克斯回归.
主要成果:
- 包括180,316名患者;80.6%接受了OAC.
- 使用OAC与死亡风险降低 (HR 0.77) 和总再入院 (HR 0.97) 有关.
- 在OAC类型 (VKA,FXaI,DTI) 之间没有发现死亡率的显著差异;在OAC中观察到中风/ICB的再入院减少 (HR 0.71).
结论:
- 在HF-AF患者中,OAC治疗与较低的死亡率和再入院率有关.
- 目前的数据并不能证明NOAC对这些终点的VKA的优越性.
- 对HF-AF患者来说,OAC仍然是一个重要的治疗策略,以改善临床结果.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies
9
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
726
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
726
Dysrhythmias V: Evaluating Dysrhythmias
41
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
41
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19


